Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system

This article discusses standard and new disruptive strategies in the race to develop an anti-COVID-19 vaccine. We also included new bioinformatic data from our group mapping immunodominant epitopes and structural analysis of the spike protein. Another innovative approach reviewed here is the use of BCG vaccine as priming strategy and/or delivery system expressing SARS-CoV-2 antigens.
Vancouver Citation
2020 Sept;in press
COVID-19;  SARS-CoV-2;  RBD domain;  vaccines;  BCG

How to cite:

Show full item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.